For research use only. Not for therapeutic Use.
c-Myc inhibitor 6 (compound A102) is a c-Myc inhibitor. c-Myc inhibitor 6 decreases cancer cell viability and degrades c-Myc protein. c-Myc inhibitor 6 can be used for the research of c-Myc imbalance, such as cancer, cardiovascular diseases, and viral infection[1].
c-Myc inhibitor 6 (0-10 μM; 72 hours) inhibits cell viability of HL-60 with an IC50 value <100 nM[1].
c-Myc inhibitor 6 (100, 300 and 1000 nM; 24 hours) dose-dependently degrades c-Myc protein in HL-60 cells[1].
Catalog Number | I041762 |
CAS Number | 2768765-58-6 |
Synonyms | [(1R)-1-[3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoylamino]-3-methylbutyl]boronic acid |
Molecular Formula | C23H29BN2O5 |
Purity | ≥95% |
InChI | InChI=1S/C23H29BN2O5/c1-15(2)13-21(24(29)30)26-22(27)11-12-25-23(28)31-14-20-18-9-5-3-7-16(18)17-8-4-6-10-19(17)20/h3-10,15,20-21,29-30H,11-14H2,1-2H3,(H,25,28)(H,26,27)/t21-/m0/s1 |
InChIKey | HRTLVHQZXDHTAZ-NRFANRHFSA-N |
SMILES | B(C(CC(C)C)NC(=O)CCNC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)(O)O |
Reference | [1]. Tong, Youzhi, et al. C-myc protein inhibitor, preparation method therefor, and use thereof. WO2022089556. 2021. |